1. From the Institute of Hematology and Medical Oncology “Seràgnoli,” University of Bologna, Bologna; CEINGE Advanced Biotechnologies and Department of Biochemistry and Medical Biotechnology, University of Naples “Federico II,” Naples; Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, Turin; and Novartis Pharma, Origgio, Italy